Metabolic and hemodynamic effects of the growth hormone system insulin-like growth factor

被引:1
作者
Manhylova, T. A. [1 ]
Gafarova, N. H. [1 ]
机构
[1] VI Vernadsky Crimean Fed Univ, SI Georgievsky Med Acad, Simferopol, Republic Of Cri, Ukraine
关键词
growth factor; insulin-like growth factor; hypertension; diabetes mellitus; obesity; CARDIOVASCULAR-DISEASE RISK; FACTOR-I; BLOOD-PRESSURE; IGF-I; ESSENTIAL-HYPERTENSION; GLUCOSE-TOLERANCE; BINDING PROTEIN-3; MEN; GH; DEFICIENCY;
D O I
10.17116/terarkh20158712128-133
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Significant congenital deficiency of growth factor (GF) results in pituitary nanism (dwarfism) and its substantial excess is accompanied by the development of gigantism or acromegaly. Its impact on the growth of the whole body or its individual parts is impossible without affecting metabolic processes and hemodynamic parameters. A number of investigations have proven that GF has a direct lipolytic effect: adequate replacement therapy for pituitary nanism gives rise to a reduction in fat depots. Since the concentration of GF is lower in obesity, whether it may be used to treat this abnormality is considered.
引用
收藏
页码:128 / 133
页数:6
相关论文
共 49 条
[1]   The Insulin-Like Growth Factor System, Metabolic Syndrome, and Cardiovascular Disease Risk [J].
Akanji, Abayomi O. ;
Smith, Robert J. .
METABOLIC SYNDROME AND RELATED DISORDERS, 2012, 10 (01) :3-13
[2]   INSULIN-LIKE GROWTH FACTOR-I AND SODIUM-LITHIUM COUNTERTRANSPORT IN ESSENTIAL-HYPERTENSION AND IN HYPERTENSIVE LEFT-VENTRICULAR HYPERTROPHY [J].
ANDRONICO, G ;
MANGANO, MT ;
NARDI, E ;
MULE, G ;
PIAZZA, G ;
CERASOLA, G .
JOURNAL OF HYPERTENSION, 1993, 11 (10) :1097-1101
[3]  
Arnetz L., 2013, ISRN ENDOCRINOL, V2013, DOI DOI 10.1155/2013/148497
[4]  
Attallah Hamdee, 2007, PLoS Clin Trials, V2, pe21, DOI 10.1371/journal.pctr.0020021
[5]   Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy [J].
Attallah, Hamdee ;
Friedlander, Anne L. ;
Hoffman, Andrew R. .
GROWTH HORMONE & IGF RESEARCH, 2006, 16 :S62-S67
[6]   Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia [J].
Barreto, JAS ;
Alcântara, MRS ;
Salvatori, R ;
Barreto, MA ;
Sousa, ACS ;
Bastos, V ;
Souza, AH ;
Pereira, RMC ;
Clayton, PE ;
Gill, MS ;
Aguiar-Oliveira, MH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05) :2018-2023
[7]  
Bartke A, 2013, ENDOKRYNOL POL, V64, P46
[8]   The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations [J].
Berryman, Darlene E. ;
Glad, Camilla A. M. ;
List, Edward O. ;
Johannsson, Gudmundur .
NATURE REVIEWS ENDOCRINOLOGY, 2013, 9 (06) :346-356
[9]   Pathogenesis and prevalence of hypertension in acromegaly [J].
Bondanelli M. ;
Ambrosio M.R. ;
degli Uberti E.C. .
Pituitary, 2001, 4 (4) :239-249
[10]   GH and IGF1: Roles in Energy Metabolism of Long-Living GH Mutant Mice [J].
Brown-Borg, Holly M. ;
Bartke, Andrzej .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2012, 67 (06) :652-660